NYMOX PHARMACEUTICAL CORP (NYMXF)
9900 CAVENDISH BLVD., SUITE 306, ST. LAURENT, QUEBEC CANADA, Quebec, Canada, H4M 2V2
Showing data for
| Sector / Industry: | Healthcare / Biotechnology | ||
| Total Shares: | - | Market Cap: | - |
| Shares Held by Institutions1 : | - | Institutional %: | - % |
| Shareholder Base Turnover2 : | % | Concentration of Institutional Shareholder Base3 : | 0 % |
| Percentage Initiated in Last One Year4 : | 0 % | Percentage Initiated in Last Two Years4 : | 0 % |
| Number of Hedge Funds: | - | Percentage Held by Hedge Funds: | 0 % |
Notes:
1. Includes all shares reported on SEC's Form 13F filings
2. Turnover is calculated as the lower of shares bought or sold during the period divided by the average shares held by institutions
3. Concentration measure is the HHI index and is calculated by squaring the fraction held by each institutional holder and then summing the resulting numbers
4. Percentage initiated in period is the number of shares owned by institutional holders that initiated their position in the period
Showing data for
| Fund | Title of Class | Value ($mm) | Actions |
|---|
| Rank | Name | Options | Total | Shares O/S (%) | Dollar Value ($mm) | Current Dollar Value ($mm) | Previously Owned | Position Initiated Period | Quality | Value | Small Size | Volatility | Momentum | Dividend | Revenue Growth (YoY) | Revenue Growth (3 Yrs) | Portfolio % | Portfolio Position | Fund Size ($mm) | Change | Est. Cost Basis | Est. Gain / Loss % | Qtr End Gain / Loss % | Investor Type | Classification | Peers Held | Actions |
|---|
| Name | Last Reported On | Total | Position Initiated Period | Number of Quarters Held | Portfolio Percentage | Portfolio Position | Est. Cost Basis | Est. Gain / Loss % | Actions |
|---|
| Fund Name | Previous. Num. Shares | Difference | Num. Shares | Previous Dollar Value ($mm) | Dollar Value Difference ($mm) | Current Dollar Value ($mm) | Position Initiated | Est. Cost Basis | Est. Gain / Loss | Actions |
|---|
** - Stocks bought during IPO
| Fund Name | Previous. Num. Shares | Difference | Num. Shares | Previous Dollar Value ($mm) | Dollar Value Difference ($mm) | Current Dollar Value$($mm) | Position Initiated | Actions |
|---|
| Rank | Name | Fund Types | Index Fund | Fund Ticker | Advisors | Reporting Period | Portfolio Percentage | Company Percentage | Number of Shares | Value ($ mn) | Classification | Net Assets ($ mn) | Quality | Value | Small Size | Volatility | Momentum | Dividend | Revenue Growth (YoY) | Revenue Growth (3 Yrs) | Actions |
|---|
| Rank | Name | Fund Types | Reporting Period | Portfolio Percentage | Company Percentage | Number of Shares | Value ($ mn) | Net Assets ($ mn) | Actions |
|---|
Buy/Sell History
| Fund | Q2-2013 | Q3-2013 | Q4-2013 | Q1-2014 | Q2-2014 | Q3-2014 | Q4-2014 | Q1-2015 | Q2-2015 | Q3-2015 | Q4-2015 | Q1-2016 | Q2-2016 | Q3-2016 | Q4-2016 | Q1-2017 | Q2-2017 | Q3-2017 | Q4-2017 | Q1-2018 | Q2-2018 | Q3-2018 | Q4-2018 | Q1-2019 | Q2-2019 | Q3-2019 | Q4-2019 | Q1-2020 | Q2-2020 | Q3-2020 | Q4-2020 | Q1-2021 | Q2-2021 | Q3-2021 | Q4-2021 | Q1-2022 | Q2-2022 | Q3-2022 | Q4-2022 | Q1-2023 | Q2-2023 | Q3-2023 | Q4-2023 | Q1-2024 | Q2-2024 | Q3-2024 | Q4-2024 | Current Number of Shares | Actions |
|---|